These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33879983)

  • 1. Development of in-house ELISAs for the detection of anti-SARS‑CoV‑2 RBD and N IgG and IgM antibodies in biological samples.
    Ibrahim EH; Ghramh HA; Kilany M
    J King Saud Univ Sci; 2021 Jun; 33(4):101439. PubMed ID: 33879983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of ELISA Using Total Antibody against Plant-Expressed Recombinant Nucleocapsid Protein of SARS-CoV-2.
    Tariq M; Hur J; Seo JW; Kim DY; Yun NR; Lee YM; Bang MS; Hwang SY; Kim CM; Lee JH; Song KH; Lee H; Jung J; Park JY; Kim HB; Kim ES; Lee S; Kim DM
    Microbiol Spectr; 2021 Dec; 9(3):e0067221. PubMed ID: 34817278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance estimation of two in-house ELISA assays for COVID-19 surveillance through the combined detection of anti-SARS-CoV-2 IgA, IgM, and IgG immunoglobulin isotypes.
    Ramírez-Reveco A; Velásquez G; Aros C; Navarrete G; Villarroel-Espíndola F; Navarrete M; Fica A; Plaza A; Castro N; Verdugo C; Acosta-Jamett G; Verdugo CC
    PLoS One; 2023; 18(2):e0270388. PubMed ID: 36745590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda.
    Oluka GK; Namubiru P; Kato L; Ankunda V; Gombe B; Cotten M; ; Musenero M; Kaleebu P; Fox J; Serwanga J
    Front Immunol; 2023; 14():1113194. PubMed ID: 36999017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19
    Yuen RR; Steiner D; Pihl RMF; Chavez E; Olson A; Smith EL; Baird LA; Korkmaz F; Urick P; Sagar M; Berrigan JL; Gummuluru S; Corley RB; Quillen K; Belkina AC; Mostoslavsky G; Rifkin IR; Kataria Y; Cappione AJ; Gao W; Lin NH; Bhadelia N; Snyder-Cappione JE
    Front Immunol; 2021; 12():614676. PubMed ID: 33897682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current state of diagnostic, screening and surveillance testing methods for COVID-19 from an analytical chemistry point of view.
    Martín J; Tena N; Asuero AG
    Microchem J; 2021 Aug; 167():106305. PubMed ID: 33897053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of robust, indigenous ELISA for detection of IgG antibodies against CoV-2 N and S proteins: mass screening.
    Srivastava AK; Gupta A; Chauhan D; Meena RC; Sugadev R; Eslavath MR; Gupta H; Karuna ; Singh S; Singh Y; Tiwari RP; Kohli V; Varshney R; Ganju L
    Appl Microbiol Biotechnol; 2022 Sep; 106(18):6225-6238. PubMed ID: 35976427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A gold nanoparticles-based lateral flow assay utilizing baculovirus expressed recombinant nucleocapsid and receptor binding domain proteins for serodetection of IgG and IgM against SARS-CoV-2.
    Salem R; Elshamy AM; Kamel N; Younes S; Marie OM; Waly FR; El-Kholy AA; Elmenofy W
    Biotechnol Lett; 2022 Dec; 44(12):1507-1517. PubMed ID: 36319880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Performance of Detection of Immunoglobulin G and Immunoglobulin M Antibody Against Spike Protein of SARS-CoV-2 by a Rapid Kit in a Real-Life Hospital Setting.
    Irungbam M; Chitkara A; Singh VK; Sonkar SC; Dubey A; Bansal A; Shrivastava R; Goswami B; Manchanda V; Saxena S; Saxena R; Garg S; Husain F; Talukdar T; Kumar D; Koner BC
    Front Microbiol; 2022; 13():802292. PubMed ID: 35558113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study.
    Horn MP; Jonsdottir HR; Brigger D; Damonti L; Suter-Riniker F; Endrich O; Froehlich TK; Fiedler M; Largiadèr CR; Marschall J; Weber B; Eggel A; Nagler M
    Allergy; 2022 Jul; 77(7):2090-2103. PubMed ID: 34986501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients.
    Pas SD; Streefkerk RH; Pronk M; de Man RA; Beersma MF; Osterhaus AD; van der Eijk AA
    J Clin Virol; 2013 Dec; 58(4):629-34. PubMed ID: 24210958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections.
    Luo J; Brakel A; Krizsan A; Ludwig T; Mötzing M; Volke D; Lakowa N; Grünewald T; Lehmann C; Wolf J; Borte S; Milkovska-Stamenova S; Gabert J; Fingas F; Scholz M; Hoffmann R
    Virol J; 2022 Mar; 19(1):50. PubMed ID: 35305688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia.
    Woo PC; Lau SK; Wong BH; Tsoi HW; Fung AM; Kao RY; Chan KH; Peiris JS; Yuen KY
    J Clin Microbiol; 2005 Jul; 43(7):3054-8. PubMed ID: 16000415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies.
    Tré-Hardy M; Wilmet A; Beukinga I; Favresse J; Dogné JM; Douxfils J; Blairon L
    J Med Virol; 2021 Feb; 93(2):803-811. PubMed ID: 32667733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity.
    McAndrews KM; Dowlatshahi DP; Dai J; Becker LM; Hensel J; Snowden LM; Leveille JM; Brunner MR; Holden KW; Hopkins NS; Harris AM; Kumpati J; Whitt MA; Lee JJ; Ostrosky-Zeichner LL; Papanna R; LeBleu VS; Allison JP; Kalluri R
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32796155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid Generation of In-House Serological Assays Is Comparable to Commercial Kits Critical for Early Response to Pandemics: A Case With SARS-CoV-2.
    Auerswald H; Eng C; Lay S; In S; Eng S; Vo HTM; Sith C; Cheng S; Delvallez G; Mich V; Meng N; Sovann L; Sidonn K; Vanhomwegen J; Cantaert T; Dussart P; Duong V; Karlsson EA
    Front Med (Lausanne); 2022; 9():864972. PubMed ID: 35602487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Fast SARS-CoV-2 IgG ELISA, Based on Receptor-Binding Domain, and Its Comparative Evaluation Using Temporally Segregated Samples From RT-PCR Positive Individuals.
    Mehdi F; Chattopadhyay S; Thiruvengadam R; Yadav S; Kumar M; Sinha SK; Goswami S; Kshetrapal P; Wadhwa N; Chandramouli Natchu U; Sopory S; Koundinya Desiraju B; Pandey AK; Das A; Verma N; Sharma N; Sharma P; Bhartia V; Gosain M; Lodha R; Lamminmäki U; Shrivastava T; Bhatnagar S; Batra G
    Front Microbiol; 2020; 11():618097. PubMed ID: 33552028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of three recombinant antigen-based enzyme immunoassays for detection of IgM and IgG antibodies to human parvovirus B19.
    Pickering JW; Forghani B; Shell GR; Wu L
    Clin Diagn Virol; 1998 Jan; 9(1):57-63. PubMed ID: 9562859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of in House ELISAs to Detect Antibodies to SARS-CoV-2 in Infected and Vaccinated Humans by Using Recombinant S, S1 and RBD Proteins.
    Yilmaz A; Turan N; Kocazeybek BS; Dinc HO; Tali HE; Aydin O; Tali HB; Yilmaz SG; Konukoglu D; Borekci S; Bold D; Roman Sosa G; Gungordu N; Vardaloglu I; Gareayaghi N; Guzel M; Guner E; Sadeyen JR; Chang P; Iqbal M; Richt JA; Yilmaz H
    Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of in-house, indirect ELISAs for the detection of SARS-CoV-2 spike protein-associated serology in COVID-19 patients in Panama.
    de la Guardia C; Rangel G; Villarreal A; Goodridge A; Fernández PL; Lleonart R
    PLoS One; 2021; 16(9):e0257351. PubMed ID: 34520491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.